You are here: Home » Reuters » News
Business Standard

China's Fosun Pharma to buy smaller stake in Indian firm for $1.1bn

Reuters  |  BEIJING/MUMBAI 

By Dominique Patton and Zeba SiddiquiBEIJING/MUMBAI (Reuters) - Shanghai Fosun Pharmaceutical Group has agreed to cut the size of the stake it will buy in India's Gland Pharma to 74 percent, it said on Sunday, paying about $1.1 billion for what is still set to be China's biggest acquisition in India.Fosun had previously sought an 86 percent stake valued at about $1.26 billion, but the deal had raised concerns among some in New Delhi, a source told Reuters.Rules issued in June stipulate that foreign investors can buy equity stakes of up to 74 percent in India's pharmaceutical companies without ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Sun, September 17 2017. 20:41 IST
RECOMMENDED FOR YOU